Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies.
Sci Rep. 2024 Feb 23;14(1):4461. doi: 10.1038/s41598-024-55080-y.
Sci Rep. 2024.
PMID: 38396175
Free PMC article.
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma.
Cicirò Y, Ragusa D, Nevado PT, Lattanzio R, Sala G, DesRochers T, Millard M, Andersson MK, Stenman G, Sala A.
Cicirò Y, et al.
FEBS Lett. 2024 Jan;598(2):252-265. doi: 10.1002/1873-3468.14786. Epub 2023 Dec 27.
FEBS Lett. 2024.
PMID: 38112379
Item in Clipboard
Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles.
Ragusa D, Cicirò Y, Federico C, Saccone S, Bruno F, Saeedi R, Sisu C, Pina C, Sala A, Tosi S.
Ragusa D, et al. Among authors: ciciro y.
Oncogenesis. 2022 Sep 3;11(1):50. doi: 10.1038/s41389-022-00426-2.
Oncogenesis. 2022.
PMID: 36057683
Free PMC article.
Item in Clipboard
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.
Cicirò Y, Sala A.
Cicirò Y, et al.
Oncogenesis. 2021 Feb 26;10(2):19. doi: 10.1038/s41389-021-00309-y.
Oncogenesis. 2021.
PMID: 33637673
Free PMC article.
Review.
Item in Clipboard
Cite
Cite